Submitted by Anonymous (not verified) on 27 February 2025 - 8:48
Human medicines European public assessment report (EPAR): Biktarvy, bictegravir,emtricitabine,tenofovir alafenamide, Date of authorisation: 21/06/2018, Revision: 18, Status: Authorised
Source: